Table 1 Baseline characteristics of BACLO-PTSD patients at the time of the BACLO-REA study (June 2016 to February 2019).
Characteristics | Baclofene N = 46 | Placebo N = 48 | p-value |
|---|---|---|---|
Age, Median (IQR) | 54.5 [43 ;65] | 57 [45.5;62.5] | 0.56 |
Sex : Male, n (%) | 37 (80.4%) | 44 (91.7%) | 0.11 |
Body Mass Index, Median (IQR) | 25.7 [22.3;28.8] | 28.5 [22.4;31.5] | 0.76 |
SAPS II a, Median (IQR) | 42 [29 ;48] | 40 [32 ;52.5] | 0.79 |
SOFAb, Median (IQR) | 7 [4 ;10] | 6 [3 ;10] | 0.90 |
Diabetes, n (%) | 4 (8.7%) | 7 (14.6%) | 0.37 |
Cirrhosis, n (%) | 0 (0%) | 1 (2.1%) | 0.99 |
Characteristics of substance use | |||
Tobacco, n (%) | 28 (60.9%) | 27 (56.3%) | 0.65 |
Units of alcohol intake per day c, Median (IQR) | 6 [4 ;10] | 5 [3 ;10] | 0.30 |
Prior alcohol withdrawal attempts d, n (%) | 13 (28.3%) | 7 (14.6%) | 0.10 |
Alcohol abuse e, n (%) | 16 (34.8%) | 18 (37.5%) | 0.94 |
Alcohol dependencee, n (%) | 14 (30.4%) | 11 (22.9%) | 0.39 |
Drugs use d, n (%) | 4 (8.7%) | 0 (0%) | 0.053 |
Hospitalization informations | |||
Reason for ICU admission, n (%) | 0.29 | ||
Medical | 36 (78.3%) | 33 (68.8%) | |
Surgical | 10 (21.7%) | 15 (31.3%) | |
Diagnosis leading to hospitalization n (%) | |||
Acute respiratory distress syndrom | 18 (39.1%) | 17 (35.4%) | |
Septic shock | 9 (19.6%) | 6 (12.5%) | |
Trauma | 6 (13.0%) | 10 (20.8%) | |
Altered Mental statusf | 3 (6.5%) | 1 (2.1%) | |
Overdose or toxic ingestion | 0 (0%) | 2 (4.2%) | |
Pancreatidis | 4 (8.7%) | 4 (8.3%) | |
Delirium tremens | 1 (2.2%) | 3 (6.3%) | |
Postoperative care | 3 (6.5%) | 2 (4.2%) | |
Pneumonia | 2 (4.3%) | 1 (2.1%) | |
Hemorragic shock | 0 (0%) | 1 (2.1%) | |
Acute liver failure | 0 (0%) | 1 (2.1%) | |